Drug intelligence / Profile preview

Okuzell

Development stage
Unknown
Lead developer
Pharmaselect International
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Okuzell is a range of ophthalmic lubricant eye drops developed by Pharmaselect International, primarily indicated for the management of dry eye syndrome (keratoconjunctivitis sicca) and ocular surface irritation. The product line includes several specialized formulations: Okuzell one (0.2% sodium hyaluronate), Okuzell forte (0.4% sodium hyaluronate for intensive lubrication), Okuzell lipid (combining sodium hyaluronate with lipids to stabilize the evaporative layer of the tear film), and Okuzell relief (containing soothing agents). The primary active ingredient, sodium hyaluronate, is a high-molecular-weight viscoelastic polysaccharide that mimics the properties of natural tears. It functions by binding to water and adhering to the corneal epithelium, thereby stabilizing the tear film, reducing moisture evaporation, and protecting the ocular surface from friction-induced damage during blinking.

Brand names
OkuzellOkuzell oneOkuzell forteOkuzell lipidOkuzell relief
Other names
sodium hyaluronate eye drops

Beyond the preview

Go deeper on Okuzell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Okuzell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call